Abstract:Objective: infection is a leading cause of morbidity and mortality in neonates. The aim of this study was to evaluate the diagnostic and prognostic performances of urinary interleukin-18 (uIL-18) and serum amyloid A (SAA) in neonatal sepsis parallel to C- reactive protein (CRP). Subjects and methods: A total of 275 neonates were included in this case-control study. This study was conducted in neonatal intensive care unit at both Minia University Hospital for obstetric and pediatrics as well as Qena University hospital (Egypt). Among those 275 neonates, 150 non septic neonates - who had neither clinical signs nor laboratory findings suggestive of sepsis - were involved as a non-septic control group (Group II) and 125 septic neonates were classified as a septic group (group I). Blood and urine samples were obtained before initiation of antibiotic therapy. Full sepsis screen was performed at the time of sepsis onset plus measurement of SAA and uIL-18 by Enzyme Immune Assay (EIA). A second blood and urine samples were collected 72 hours later. The effectiveness of these 3 biomarkers as diagnostic ones was determined by using receiver operating characteristic (ROC) curve analysis. We also calculated the sensitivity, specificity, and positive, and negative predictive values. Results: The levels of uIL-18 and SAA were significantly elevated in septic neonates than in control group. The two markers showed significant decrease in their levels after 72 hours which matched with clinical improvement but not CRP. Moreover, very high levels of these markers were observed in neonates who died later on. The area under ROC curve (AUC) was used to evaluate the diagnostic efficacies of these markers. The superiority of SAA over both uIL-18 and CRP was obvious in the diagnosis of neonatal sepsis [AUC: 0.995] versus [AUC: 0.934 (uIL-18) and 0.871 (CRP)]. However in discriminating late onset sepsis (LOS), both uIL-18 and SAA have equal diagnostic capacities [AUC: 44 0.991] which are better than that of CRP [AUC: 0.866]. As to EOS, SAA has the most efficient performance as well but CRP is advanced than uIL-18. The specificities and sensitivities of either SAA or uIL-18 were higher than that of CRP in differentiating neonatal sepsis mainly LOS from controls. Conclusion: Both uIL-18 and SAA have enhanced performance over CRP for distinguishing neonatal sepsis mostly for LOS. Thus, they could be promising biomarkers for the screening and follow up of neonatal sepsis. This warrants further assessment of their prognostic values.

Role of IL-18 in Comparison to Serum Creatinine in Early Detection of Sepsis Induced Acute Kidney Injury in Emergency Department in Suez Canal University Hospital

Serum Interleukin-18, Kidney Injury Molecule-1, and the Renal Resistive Index for Predicating Acute Kidney Injury in Critically Ill Patients with Sepsis.

Protocol for a Prospective Observational Study on the Association of Variables Obtained by Contrast-Enhanced Ultrasonography and Sepsis-Associated Acute Kidney Injury

Serum cystatin C, kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, klotho and fibroblast growth factor-23 in the early prediction of acute kidney injury associated with sepsis in a Chinese emergency cohort study

Renal arterial resistive index versus novel biomarkers for the early prediction of sepsis-associated acute kidney injury

Kidney injury molecule type-1, interleukin-18, and insulin-like growth factor binding protein 7 levels in urine to predict acute kidney injury in pediatric sepsis

Serum cystatin C and serum lactate levels as diagnostic and prognostic markers in acute kidney injury in critically ill patients

Assessment of Urinary Interleukin-18 and Serum Amyloid A Efficacies against C-Reactive Protein in Diagnosis and Follow-up of Neonatal Sepsis

Impact of sepsis on the urinary level of interleukin-18 and cystatin C in critically ill neonates

Prognostic value of serum levels of multiple adhesion factors in patients with sepsis-induced acute kidney injury

Value of early diagnosis of sepsis complicated with acute kidney injury by renal contrast-enhanced ultrasound

Prevention and Early Detection of Acute Kidney Injury in Intensive Care Unit: A Systematic Review

Recent Advances on Biomarkers of Sepsis-induced Acute Kidney Injury

Identification of Biomarkers for the Diagnosis of Sepsis-Associated Acute Kidney Injury and Prediction of Renal Recovery in the Intensive Care Unit

The Early Diagnostic Value of Tissue Inhibitor of Matrix Metalloproteinase-2 and Insulin-Like Growth Factor Binding Protein-7 in Sepsis-Induced Acute Kidney Injury

The diagnostic and prognostic values of serum and urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin in sepsis induced acute renal injury patients

Assessment of the Significance of Cysteine Proteinase Inhibitor C and Β2 Microgiobulin in the Diagnosis and Prognosis of Sepsis-Induced Acute Kidney Injury

Analysis of Spatiotemporal Urine Protein Dynamics to Identify New Biomarkers for Sepsis-Induced Acute Kidney Injury

Biomarkers for the Diagnosis of Sepsis-Associated Acute Kidney Injury: Systematic Review and Meta-Analysis

Predictive Value of Systemic Immune Inflammation Index in Septic Patients with Acute Kidney Injury

[Urinary Neutrophil Gelatinase-Associated Lipocalin and Urinary Interleukin-18 in Early Diagnosis of Acute Kidney Injury in Critically Ill Patients].